Nandabalan Krishnan is a director of BioXcel Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BioXcel Therapeutics, Inc.
10 Apr 23
5
BioXcel Therapeutics, Inc.
14 Feb 23
4
BioXcel Therapeutics, Inc.
6 Jan 23
4
BioXcel Therapeutics, Inc.
14 Nov 22
5
BioXcel Therapeutics, Inc.
14 Feb 22
4
BioXcel Therapeutics, Inc.
29 Jun 21
5
BioXcel Therapeutics, Inc.
16 Feb 21
4
BioXcel Therapeutics, Inc.
16 Feb 21
4
BioXcel Therapeutics, Inc.
13 May 20
4
BioXcel Therapeutics, Inc.
28 Apr 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Apr 23 | BTAI BioXcel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 17.32 | 60,000 | 1.04 mm | 0 |
6 Apr 23 | BTAI BioXcel Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.41 | 60,000 | 24.60 k | 60,000 |
6 Apr 23 | BTAI BioXcel Therapeutics | Stock Options Common Stock | Option exercise | Dispose M | No | No | 0.41 | 60,000 | 24.60 k | 294,000 |
5 Jan 23 | BTAI BioXcel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 22.93 | 800 | 18.34 k | 0 |
5 Jan 23 | BTAI BioXcel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 22.32 | 25,089 | 559.99 k | 800 |
5 Jan 23 | BTAI BioXcel Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.41 | 25,889 | 10.61 k | 25,889 |
5 Jan 23 | BTAI BioXcel Therapeutics | Stock Options Common Stock | Option exercise | Dispose M | No | No | 0.41 | 25,889 | 10.61 k | 354,000 |
4 Jan 23 | BTAI BioXcel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 22.21 | 9,821 | 218.12 k | 0 |
4 Jan 23 | BTAI BioXcel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 21.59 | 24,290 | 524.42 k | 9,821 |
4 Jan 23 | BTAI BioXcel Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.41 | 34,111 | 13.99 k | 34,111 |